DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Sheraton Pentagon City Hotel

2024年3月12日 (火) 午前 7:30 - 2024年3月13日 (水) 午後 3:55

900 South Orme Street, Arlington, VA 22204, USA

Advertising and Promotion Regulatory Affairs Conference

Explore the current state of compliance for marketing both biopharmaceuticals and medical devices.

Session 11: Unlocking the Future: Leveraging AI in Promotional Review Processes for Enhanced Compliance and Efficiency

Session Chair(s)

Moulakshi  Roychowdhury, JD, PharmD

Moulakshi Roychowdhury, JD, PharmD

Global Head, Regulatory Affairs, Advertising & Promotion, Allergan Aesthetics

AbbVie, United States

In this session, we will better understand the potential of utilizing AI in the various parts of the promotional review process. The session will include non-promotional case studies to understand existing applications and showcase current AI tools, their applications, industry interests, necessary capabilities, and ideal states for value.

Key topics covered will include best practices for seamlessly integrating new Cplatforms into advertising, addressing internal guidance, consistency, above-brand/BU governance, and SOPs for the exploration of new technology. The session will delve into the effective use of AI as a compliance tool, particularly for tracking changes in digital platforms. Moreover, participants will engage in discussions around creating internal AI tools for promotional review, criteria used, and essential considerations for a wishlist. The session will conclude by assessing the efficiencies and existing applications of AI tools, with a special focus on the potential utilization of ChatGPT by reviewers.

Learning Objective :
  • Examine insights into best practices for incorporating new platforms into advertising
  • Determine how AI can be leveraged as a compliance tool
  • Discuss criteria for internal AI tools and explore their applications
  • Identify potential applications of ChatGPT for promo review

Speaker(s)

Nazeer  Ahmed, MS

AI 101

Nazeer Ahmed, MS

Allergan, United States

Associate Director (acting) for MLRC

Jia-Huey  Huey, PharmD, RPh

Reg Considerations for AI

Jia-Huey Huey, PharmD, RPh

Johnson & Johnson Office of Health Care Compliance & Privacy, United States

Group Leader, Regulatory Advertising and Promotion

Shakshi  Kshatriya

Reg Considerations for AI

Shakshi Kshatriya

Abbvie, United States

Associate Director, Advertising and Promotion

Dara S. Katcher Levy, JD

Speaker

Dara S. Katcher Levy, JD

Hyman Phelps & McNamara P.C., United States

Director

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。